RC 344

Tocilizumab IV infusion for hospitalized COVID-19 patients at Mercy Rehabilitation Hospital, LLC

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

I-131 NA IODID SOL TX/MCI

Smith, AR

See all hospitals reporting RC 344 →

SharePost on X LinkedIn

Pricing by billing methodology

Price type

How this price compares nationally

Mercy Rehabilitation Hospital, LLC’s median price of $19.3k is 7371% above the median hospital's median price ($258), higher than 97% of the 1,329 hospitals reporting RC 344. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Mar 16, 2026

Compare to other hospitals

See Tocilizumab IV infusion for hospitalized COVID-19 patients pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.